1. Li, Zhuoqi, Zheng, Chunning, Liu, Hongtao, Zhang, Chi, Tian, Yuan. 2023. A novel oxidative stress-related gene signature as an indicator of prognosis and immunotherapy responses in HNSCC. In Aging, 15, 14957-14984. doi:10.18632/aging.205323. https://pubmed.ncbi.nlm.nih.gov/38157249/
2. Zhang, Xiyang, Wang, Jing, Liang, Xiaohua, Yang, Shuya, Yang, Kun. 2025. BAP31-ELAVL1-SPINK6 axis induces loss of cell polarity and promotes metastasis in hepatocellular carcinoma. In International journal of biological sciences, 21, 1632-1648. doi:10.7150/ijbs.102566. https://pubmed.ncbi.nlm.nih.gov/39990675/
3. Kim, Hyun Je, Shim, Joon Ho, Park, Ji-Hye, Yang, Jun-Mo, Lee, Dongyoun. 2021. Single-cell RNA sequencing of human nail unit defines RSPO4 onychofibroblasts and SPINK6 nail epithelium. In Communications biology, 4, 692. doi:10.1038/s42003-021-02223-w. https://pubmed.ncbi.nlm.nih.gov/34099859/
4. Lu, Hairong, Huang, Jinjiang, Li, Guodong, Wu, Hongyu, Huang, Qingshan. 2011. Expression, purification and characterization of recombinant human serine proteinase inhibitor Kazal-type 6 (SPINK6) in Pichia pastoris. In Protein expression and purification, 82, 144-9. doi:10.1016/j.pep.2011.12.004. https://pubmed.ncbi.nlm.nih.gov/22212898/
5. Nie, Qian, Cao, Huan, Yang, Jianwang, Liu, Tao, Wang, Baoshan. 2024. Integration RNA bulk and single cell RNA sequencing to explore the change of glycolysis-related immune microenvironment and construct prognostic signature in head and neck squamous cell carcinoma. In Translational oncology, 46, 102021. doi:10.1016/j.tranon.2024.102021. https://pubmed.ncbi.nlm.nih.gov/38850799/
6. Ge, Kuikui, Huang, Jinjiang, Wang, Wei, Zhong, Jiang, Huang, Qingshan. . Serine protease inhibitor kazal-type 6 inhibits tumorigenesis of human hepatocellular carcinoma cells via its extracellular action. In Oncotarget, 8, 5965-5975. doi:10.18632/oncotarget.13983. https://pubmed.ncbi.nlm.nih.gov/27999203/
7. Fischer, J, Meyer-Hoffert, U. 2013. Regulation of kallikrein-related peptidases in the skin - from physiology to diseases to therapeutic options. In Thrombosis and haemostasis, 110, 442-9. doi:10.1160/TH12-11-0836. https://pubmed.ncbi.nlm.nih.gov/23446429/
智鼠故事 
